Investors in Switzerland

Planven is a venture capital fund with an innovative focus on combining established industries with cutting edge growth stage technology companies. We invest in disruptive technologies that have direct impact on European businesses. Scalable business models and outstanding founders. We support our portfolio companies throughout their global expansion, connecting them with the scale of established multinational corporates

The Quan Funds are a family of absolute-return funds. Our flagship fund, the Quan Technology Fund, is a crossover fund investing in private and public technology companies. The Fund is open-ended, providing quarterly liquidity to investors based on the Fund’s liquid net asset value.

Founded by Tyron Birkmeir, Lurra Capital is an invitation-only private capital investment firm combining specialist expertise with innovative and alternative investment solutions to ultra-high net worth investors and families. Lurra's strategy encompasses exclusive, highly sought-after investments in the core areas of real estate, private equity and venture capital. Its investment philosophy is focused on strategic assets with significant growth and development potential. The firm, which is headquartered in Switzerland with offices in London, Luxembourg and Miami, currently oversees $5 billion of assets.

Beyond Impact VC www.beyondimpact.vc advises in the creation of portfolios that accelerate our transition to a cruelty-free world, with a focus on : Organic crop production and distribution Plant-based meat, fish and leather alternatives Vegan convenience foods «Clean» meat, fish and leather Vegan catering and restaurants Vegan clothing and accessories Vegan lifestyle businesses. Replacements for animal testing Cruelty-free, organic household products, toiletries and cosmetics

The New Frontiers (TNF) is an international investment firm headquartered in Geneva, Switzerland with an office at the Dubai International Financial Center (DIFC) and has investments and interests across the globe. We are a focused team of recognised experts searching to unlock entrepreneurial and disruptive potential. By bringing our capital, connections, and capabilities, we are a partner in growth and a catalyst for innovation. TNF was formed over a decade ago by Erkin Bek, and invests in a concentrated set of businesses across sectors such as future financial market infrastructure, cybersecurity, trust-technology, sustainable tech and wellness, amongst others.

At Tomahawk.VC we are building the world's most transparent venture capital firm because we want to be the founders we always wished we had. We know what it's like to sit on the other side of the deal table and how essential communication is to focus and efficiency. We honour the standards we as founders expect from investors and maintain honesty, clarity, and speed as essential to providing valuable feedback and leveraging our network so that you can spend your time building the blocks for the future. We invest in FinTech & DeFi companies Pre-Seed, Seed and Series A rounds. Investments range from USD 250k-1.5M per transaction and up to USD 2M per company.

BlueOcean Ventures invests in early stage medical device and life science companies. Unlike other funds the four Founders of BlueOcean Ventures, Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz and Thomas Zehnder, have a long-standing track record in building, managing and coaching start-up companies. BlueOcean Ventures supports their portfolio companies with a large network of experts and industry contacts.

Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions. As a company builder, we identify the most promising business opportunities in the field of longevity and build companies from scratch. We provide proven structures, financing, and a unique and inspiring playground for entrepreneurs to build a longevity venture. With a team of globally successful entrepreneurs and venture investors, we have built a venture building process that bridges the gap between science and business.

Smart money for smart innovators"​ BAS, Business Angels Switzerland, is the most experienced Business Angel Club in Switzerland. We're a not-for-profit organization with chapters in Suisse Romande and in Zürich. We organize 20 events and 60 startup presentations per year. They lead to more than 10 yearly investments in all industries. Our eighty members and the startups like the familiar and friendly atmosphere of our events. The member list is not disclosed.

Privilège Ventures is a Swiss-based Venture Capital firm, authorized by the Swiss Financial Market Supervisory Authority (FINMA, www.finma.ch) as venture capital asset manager, investing in promising early-stage startups. With offices in Lugano and Zurich, we aim to support young founders on a mission to build the future. Our unique values derive from previous experiences as founders, entrepreneurs, operators and investors. We provide unceasing support, expertise, and valuable network access to help entrepreneurs forge ahead.

Convergence Partners is a European venture capital firm that invests in founders building high-impact companies in healthcare sectors with large unmet needs. The Convergence team actively drives the scale-up and internationalisation of its portfolio companies to Germany, China, US and India.

Science and technology are the emerging frontier driving the shift from sickcare to the new healthcare. Sickcare treats disease and manages symptoms.The new healthcare will proactively empower health through early and personalized care to prevent disease and extend healthy lifespan. At FORM Life Ventures, we believe that hard-nosed science will shape the future of healthcare by accelerating data-driven breakthroughs.